Ravina BM - Search Results

1

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Dorsey ER, et al. Among authors: ravina bm. Neurology. 2007 Jan 30;68(5):384-6. doi: 10.1212/01.wnl.0000247740.47667.03. Epub 2006 Nov 2. Neurology. 2007. PMID: 17082464

2

Biomarkers in Parkinson's disease.

Dorsey ER, Holloway RG, Ravina BM. Dorsey ER, et al. Among authors: ravina bm. Expert Rev Neurother. 2006 Jun;6(6):823-31. doi: 10.1586/14737175.6.6.823. Expert Rev Neurother. 2006. PMID: 16784406 Review.

3

Neuroprotection in Parkinson's disease: an elusive goal.

Biglan KM, Ravina B. Biglan KM, et al. Semin Neurol. 2007 Apr;27(2):106-12. doi: 10.1055/s-2007-971168. Semin Neurol. 2007. PMID: 17390255 Review.

4

Why hasn't neuroprotection worked in Parkinson's disease?

Kieburtz K, Ravina B. Kieburtz K, et al. Nat Clin Pract Neurol. 2007 May;3(5):240-1. doi: 10.1038/ncpneuro0491. Nat Clin Pract Neurol. 2007. PMID: 17479072 Review. No abstract available.

5

Preference-based quality-of-life in patients with Parkinson's disease.

Siderowf A, Ravina B, Glick HA. Siderowf A, et al. Neurology. 2002 Jul 9;59(1):103-8. doi: 10.1212/wnl.59.1.103. Neurology. 2002. PMID: 12105315

6

A responsive outcome for Parkinson's disease neuroprotection futility studies.

Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K; NET-PD Investigators. Elm JJ, et al. Ann Neurol. 2005 Feb;57(2):197-203. doi: 10.1002/ana.20361. Ann Neurol. 2005. PMID: 15668964

7

Local institutional review board (IRB) review of a multicenter trial: local costs without local context.

Ravina B, Deuel L, Siderowf A, Dorsey ER. Ravina B, et al. Ann Neurol. 2010 Feb;67(2):258-60. doi: 10.1002/ana.21831. Ann Neurol. 2010. PMID: 20225291 Free PMC article.

8

The role of radiotracer imaging in Parkinson disease.

Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R. Ravina B, et al. Neurology. 2005 Jan 25;64(2):208-15. doi: 10.1212/01.WNL.0000149403.14458.7F. Neurology. 2005. PMID: 15668415 Review.

9

Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs.

Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC; NET-PD Investigators. Tilley BC, et al. Neurology. 2006 Mar 14;66(5):628-33. doi: 10.1212/01.wnl.0000201251.33253.fb. Neurology. 2006. PMID: 16534099 Review.

10

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators. Parashos SA, et al. JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391. JAMA Neurol. 2014. PMID: 24711047 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters